CME Group Inc.
CMECME Group Inc. (CME) is a Financial Services company that currently yields 1.72% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $177.94 and the overvaluation threshold at $276.14. CME Group Inc. holds a quality score of 70/100 (Good), reflecting an established dividend payment history with a 43% payout ratio. The 5-year dividend CAGR stands at 8.0%.
CME Dividend Yield History — Weiss Valuation
Distance to undervalued
Entry price is stretched
Needs 38.9% downside to reach the Weiss buy zone
Undervaluation starts near $177.94, where the annual dividend would imply roughly 2.81% yield. That is 1.09% above today's yield.
Buy-zone price
$177.94
Target yield
2.81%
Research checklist
What to clear before buying the yield
Updated May 25, 2026
Dividend durability
12YLong dividend history supports a deeper look.
Earnings payout
43%Earnings coverage leaves room for noise.
Cash payout
62%Free cash flow coverage supports the payment.
Dividend growth
8.0%Recent growth adds income compounding potential.
What changed
What changed since the last update
2026-05-23 → 2026-05-25
No major change in signal, yield, price, quality, or payout since the last update.
Why Now?
CME Group Inc. is trading near its historical overvaluation band.
Current yield 1.7% vs historical max 5.9% (29% of maximum).
12 consecutive years without a dividend cut.
Conservative payout ratio of 43%.
What matters now
Read the signal before the headline yield
Valuation is the brake here: the yield is compressed versus its own history.
The 70/100 quality score calls for selective follow-up, not autopilot.
Start by checking whether payout coverage and business durability still support the dividend.
CME Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$185
Year 10 Income
$466
Yield on Cost
4.83%
Total Income
$3,033
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗CME Dividend Quality Score
Quality Score
Good
Key Metrics
Invest in CME
Buy CME Group Inc. commission-free on eToro
Start investing on eToro →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ CME Dividend Analysis Article